Mitchell Gold, Nivalis Therapeutics, Inc.'s Executive Chairman and CEO and a director of the company, appears to have filed an empty initial statement of beneficial ownership. This form is usually filed as a prelude to a company officer either receiving options or buying company shares, so there may be more to come from Gold.

Here is the filing.

To get notified when Nivalis Therapeutics, Inc. makes a similar move, sign up!

Auto Refresh